Diagnostic and Precision Medicine Advances Transforming the Biotech Landscape

Share this:
     
Published: 26 Jan 2018

This edition of the Genetic Technology TOE provides insights on recent developments and innovations in genetic diagnostics and precision medicine. The service also provides clinical trial analysis for utomilumab. The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Genetic diagnostics, hereditary disease, precision medicine, blockchain, CAR-T cell, bispecific antibody, humanized antibody, 4-1BB agonist

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..